COR THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
COR THERAPEUTICS, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INTEGRILIN. The owner is based in South San Francisco, CA.
256 East Grand Avenue, Suite 80
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
COR THERAPEUTICS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does COR THERAPEUTICS, INC. have?
COR THERAPEUTICS, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 2 cancelled.
What trademark classes does COR THERAPEUTICS, INC. file in?
COR THERAPEUTICS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are COR THERAPEUTICS, INC.'s most well-known trademarks?
COR THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as INTEGRILIN. These are among 1 currently registered trademark in the portfolio.
What is COR THERAPEUTICS, INC.'s trademark registration success rate?
COR THERAPEUTICS, INC. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.